(Circulation. 1995;92:2109-2112.)
© 1995 American Heart Association, Inc.
Articles |
From the Division of Cardiology, Department of Medicine, University Federico II, Napoli, Italy.
Correspondence to Ciro Indolfi, MD, Division of Cardiology, University Federico II, Via St Pansini 5, 80131 Napoli, Italy.
Background Coronary vasoconstriction has been
described after uncomplicated percutaneous transluminal
coronary angioplasty (PTCA). However, it is still unknown
whether this phenomenon is limited to coronary circulation. The
present study was planned to assess the effects of a successful
PTCA on forearm blood flow (FBF) and resistance. The role of
-adrenoceptors and calcium antagonist agents on
PTCA-induced limb blood flow changes was also investigated.
Methods and Results We prospectively studied 37 patients scheduled for elective single PTCA of the left anterior descending coronary artery. All patients had evidence of exercise-induced myocardial ischemia. All vasoactive drugs were withdrawn for at least 48 hours before the study. FBF was measured by calibrated venous occlusion plethysmography. A significant reduction of FBF was observed at 1, 5, and 15 minutes after PTCA (from 3.7±1.2 to 2.7±1.5, 3.0±1.6, and 2.9±1.9 mL/100 mL tissue per minute, respectively; all P<.05 versus baseline). Vascular forearm resistance also increased at 1, 5, and 15 minutes after PTCA (from 27±8 to 42±16, 37±10, and 43±19 U, respectively; all P<.05 versus baseline). Phentolamine (12 µg · kg-1 · min-1, n=7) or verapamil (3.5 µg · kg-1 · min-1, n=7) also was infused intra-arterially. PTCA-induced forearm vasoconstriction was completely abolished by pretreatment with regional infusion of phentolamine or verapamil.
Conclusions After an uncomplicated PTCA of the left anterior
descending coronary artery, a reduction in FBF and an increase
in forearm vascular resistance were observed. This
peripheral vasoconstrictive response was
probably due to
-adrenergic stimulation and was abolished by
intra-arterial infusion of calcium
antagonist agents.
Key Words: angioplasty blood flow verapamil receptors adrenergic alpha
This article has been cited by other articles:
![]() |
J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kubo, E. R. Azevedo, G. E. Newton, J. D. Parker, and J. S. Floras Lack of evidence for peripheral alpha1- adrenoceptor blockade during long-term treatment of heart failure with carvedilol J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1463 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perticone, R. Ceravolo, R. Maio, G. Ventura, A. Zingone, N. Perrotti, and P. L. Mattioli Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Endothelium-Dependent Vasodilation in Never Treated Hypertensive Patients Hypertension, April 1, 1998; 31(4): 900 - 905. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |